Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy)
Michele Ciccarelli, Fabrizio Merciai, Albino Carrizzo, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 217, pp. 114827-114827
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Deuterated Drugs and Biomarkers in the COVID-19 Pandemic
Ross D. Jansen‐van Vuuren, Luka Jedlovčnik, Janez Košmrlj, et al.
ACS Omega (2022) Vol. 7, Iss. 46, pp. 41840-41858
Open Access | Times Cited: 38
Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19
Chiara Bruzzone, Ricardo Conde, Nieves Embade, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 30
Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome
Adriano José Maia Chaves Filho, Olivia Braniff, Angelina Angelova, et al.
Brain Research Bulletin (2023) Vol. 201, pp. 110702-110702
Open Access | Times Cited: 21
Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis
Hu Meng, Arjun Sengupta, Emanuela Ricciotti, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 11
Open Access | Times Cited: 19
Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia
Chel Hee Lee, Mohammad Mehdi Banoei, Mariam Ansari, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 7
Link between organic nanovescicles from vegetable kingdom and human cell physiology: intracellular calcium signalling
Martina Trentini, Ilaria Zanolla, Elena Tiengo, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Anthocyanins from purple corn affect gut microbiota and metabolome in IBD patients under Infliximab infusion: the SiCURA pilot study
Mirco Vacca, Eduardo Sommella, Marina Liso, et al.
Deleted Journal (2024)
Open Access | Times Cited: 5
Marked elevations in lung and plasma ceramide in COVID-19 linked to microvascular injury
Irina Petrache, Elisabet Pujadas, Aditya Ganju, et al.
JCI Insight (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 12
Lipidomics signature in post-COVID patient sera and its influence on the prolonged inflammatory response
Pablo F. Garrido, L.S. Castillo-Peinado, Feliciano Priego‐Capote, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 4, pp. 588-600
Open Access | Times Cited: 4
A Diet Fortified with Anthocyanin-Rich Extract (RED) Reduces Ileal Inflammation in a Senescence-Prone Mice Model of Crohn’s-Disease-like Ileitis
Giulio Verna, Vicky Caponigro, Stefania De Santis, et al.
Antioxidants (2025) Vol. 14, Iss. 4, pp. 473-473
Open Access
Chewing the fat: How lipidomics is changing our understanding of human health and disease in 2022
Caroline Géhin, Stephen J. Fowler, Drupad K. Trivedi
Analytical Science Advances (2023) Vol. 4, Iss. 3-4, pp. 104-131
Open Access | Times Cited: 10
Network-based integrative multi-omics approach reveals biosignatures specific to COVID-19 disease phases
Francis E. Agamah, Thomas H. A. Ederveen, Michelle Skelton, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2
Quantitative proteomics analysis of COVID-19 patients: Fetuin-A and tetranectin as potential modulators of innate immune responses
Bandar Alghanem, Fatmah A. Mansour, Hayat Shaibah, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e15224-e15224
Open Access | Times Cited: 5
Deficiency in the production of antibodies to lipids correlates with increased lipid metabolism in severe COVID-19 patients
Ignacio Piédrola, Sara Martínez, Ana Gradillas, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
COVID-19 and cholesterol biosynthesis: Towards innovative decision support systems
Eva Kočar, Sonja Katz, Žiga Pušnik, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107799-107799
Open Access | Times Cited: 4
Lipid metabolism of plasma-derived small extracellular vesicles in COVID-19 convalescent patients
Wenjing Xiao, Qi Huang, Ping Luo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Untargeted metabolomics uncovers metabolic dysregulation and tissue sensitivity in ACE2 knockout mice
Lili Zhao, Weili Yang, Wenyi Ji, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27472-e27472
Open Access | Times Cited: 1
Mass spectrometry and machine learning in the identification of COVID-19 biomarkers
Lucas C. Lázari, Gilberto Santos de Oliveira, Janaína Macedo-da-Silva, et al.
Frontiers in Analytical Science (2023) Vol. 3
Open Access | Times Cited: 3
Mass spectrometric approaches in discovering lipid biomarkers for COVID‐19 by lipidomics: Future challenges and perspectives
Siddabasave Gowda B. Gowda, Chandra Shekhar, Divyavani Gowda, et al.
Mass Spectrometry Reviews (2023) Vol. 43, Iss. 5, pp. 1041-1065
Closed Access | Times Cited: 3
Associations of the Lipidome with Ageing, Cognitive Decline and Exercise Behaviours
Maria Kadyrov, Luke Whiley, Belinda M. Brown, et al.
Metabolites (2022) Vol. 12, Iss. 9, pp. 822-822
Open Access | Times Cited: 5
Deep Phenotyping of the Lipidomic Response in COVID and non-COVID Sepsis
Hu Meng, Arjun Sengupta, Emanuela Ricciotti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study
Marwa O. El-Derany, Diana M. F. Hanna, John Youshia, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 5, pp. 1045-1065
Open Access | Times Cited: 2
Computational Analysis of Plasma Lipidomics from Mice Fed Standard Chow and Ketogenic Diet
Amy L Seufert, James W Hickman, Jaewoo Choi, et al.
BIO-PROTOCOL (2023) Vol. 13, Iss. 18
Open Access | Times Cited: 2
Sub-5-min RP-UHPLC-TIMS for high-throughput untargeted lipidomics and its application to multiple matrices
Fabrizio Merciai, Manuela Giovanna Basilicata, Danila La Gioia, et al.
Analytical and Bioanalytical Chemistry (2023) Vol. 416, Iss. 4, pp. 959-970
Closed Access | Times Cited: 2
Predictive Value of Lysophosphatidylcholine for Determining the Disease Severity and Prognosis of Elderly Patients with Community-Acquired Pneumonia
Minghao Gu, SenSen Lv, Yihui Song, et al.
Clinical Interventions in Aging (2024) Vol. Volume 19, pp. 517-527
Open Access
Page 1 - Next Page

Scroll to top